Report cover image

India Multiplex Assay Market Forecast 2024-2032

Publisher Inkwood Research
Published Mar 23, 2024
Length 142 Pages
SKU # INKR18647241

Description

India Multiplex Assay Market Forecast 2024-2032


KEY FINDINGS

The India multiplex assay market growth is anticipated to progress at a CAGR of 9.58% during the forecast period, 2024-2032. The market growth is attributed to the intensified demand for advanced diagnostic solutions capable of detecting multiple biomarkers simultaneously. This is due to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.

MARKET INSIGHTS

In India, the India Against Cancer initiative was launched by the National Institute of Cancer Prevention and Research (NICPR) in collaboration with medical professionals and researchers. The primary objective of this initiative is to disseminate information on prevalent cancers, emphasizing awareness, prevention, and treatment. Among Indian women, breast cancer stands out as the most common form of cancer, constituting over 25% of all female cancer cases, with a five-year survival rate of 66.4%. Additionally, cervical cancer presents a significant concern, with a five-year survival rate of 51.7%.

India's pharmaceutical sector has a rich history of reverse engineering, demonstrating its capacity to manufacture and distribute generic versions of pharmaceutical products globally. Following the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement, Indian companies have redirected their research and development efforts towards innovative drug delivery systems and discovery research.

Furthermore, there are notable shifts in regulations concerning animal testing across Asia, with India implementing stringent measures in this domain. Notably, India has recently prohibited the testing of cosmetics on animals. These regulatory changes are expected to lead to the replacement of animal testing practices with in vitro methods, which offer enhanced sensitivity, accuracy, safety, ease of execution, and cost-effectiveness. Such factors are projected to drive the India multiplex assay market growth.

COMPETITIVE INSIGHTS

Some of the key companies in the market are Qiagen NV, Illumina Inc, Siemens Healthineers AG, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

142 Pages
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Methodology
1.3. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Country Snapshot
2.3. Country Analysis
2.4. Scope Of Study
2.5. Crisis Scenario Analysis
2.6. Major Market Findings
2.6.1. Software And Services Sector Emerges As The Rapidly Expanding Product & Service Segment
2.6.2. Protein-based Multiplex Assay Is The Highest Revenue-generating Type
2.6.3. Research & Development Applications Dominate Market Share
2.6.4. Multiplex Pcr Technology Demonstrates Faster Growth
2.6.5. Pharmaceutical And Biotechnology Companies Are Major Users Of Multiplex Assays
3. Market Dynamics
3.1. Key Drivers
3.1.1. Escalating Incidence Of Chronic Diseases
3.1.2. Growing Preference For Multiplex Assays Over Conventional Approaches
3.1.3. Increasing Acceptance Of Personalized Medicine
3.2. Key Restraints
3.2.1. Overcoming The Difficulty Of Establishing Sufficient Assay Range
3.2.2. Challenges Associated With Cross-reactivity And Assay Interference
3.2.3. Shortage Of Skilled Professionals
4. Key Analytics
4.1. Key Market Trends
4.1.1. Rising Drug Discovery Endeavors
4.1.2. Progress In Assay Platform Technology
4.1.3. Rapid Expansion Of Companion Diagnostics
4.2. Pestle Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Legal
4.2.6. Environmental
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Market Concentration Analysis
4.5. Key Buying Criteria
4.5.1. Coverage Of Analytes
4.5.2. Rapidity
4.5.3. Ability To Multiplex
4.5.4. User-friendliness
4.5.5. Automation Potential
4.6. Value Chain Analysis
4.6.1. Research And Development (R&D)
4.6.2. Manufacturing And Production
4.6.3. Distribution And Supply Chain
4.6.4. Clinical Application And Data Analysis
4.6.5. Market Research And Commercialization
5. Market By Product And Service
5.1. Reagents And Consumables
5.1.1. Market Forecast Figure
5.1.2. Segment Analysis
5.2. Instruments And Accessories
5.2.1. Market Forecast Figure
5.2.2. Segment Analysis
5.3. Software And Services
5.3.1. Market Forecast Figure
5.3.2. Segment Analysis
6. Market By Type
6.1. Protein-based Multiplex Assay
6.1.1. Market Forecast Figure
6.1.2. Segment Analysis
6.2. Nucleic Acid-based Multiplex Assay
6.2.1. Market Forecast Figure
6.2.2. Segment Analysis
6.3. Other Types
6.3.1. Market Forecast Figure
6.3.2. Segment Analysis
7. Market By Application
7.1. Research And Development
7.1.1. Market Forecast Figure
7.1.2. Segment Analysis
7.2. Clinical Diagnostics
7.2.1. Market Forecast Figure
7.2.2. Segment Analysis
7.3. Companion Diagnostics
7.3.1. Market Forecast Figure
7.3.2. Segment Analysis
8. Market By Technology
8.1. Multiplex Protein Microarray
8.1.1. Market Forecast Figure
8.1.2. Segment Analysis
8.2. Multiplex Pcr
8.2.1. Market Forecast Figure
8.2.2. Segment Analysis
8.3. Other Technologies
8.3.1. Market Forecast Figure
8.3.2. Segment Analysis
9. Market By End-user
9.1. Pharmaceutical & Biotechnology Companies
9.1.1. Market Forecast Figure
9.1.2. Segment Analysis
9.2. Research Institutes
9.2.1. Market Forecast Figure
9.2.2. Segment Analysis
9.3. Clinical Laboratories
9.3.1. Market Forecast Figure
9.3.2. Segment Analysis
9.4. Hospitals
9.4.1. Market Forecast Figure
9.4.2. Segment Analysis
10. Competitive Landscape
10.1. Key Strategic Developments
10.1.1. Mergers & Acquisitions
10.1.2. Product Launches & Developments
10.1.3. Partnerships & Agreements
10.1.4. Business Expansions & Divestitures
10.2. Company Profiles
10.2.1. Agilent Technologies Inc
10.2.1.1. Company Overview
10.2.1.2. Product Portfolio
10.2.1.3. Strengths & Challenges
10.2.2. Becton, Dickinson And Company (Bd)
10.2.2.1. Company Overview
10.2.2.2. Product Portfolio
10.2.2.3. Strengths & Challenges
10.2.3. Bio-rad Laboratories Inc
10.2.3.1. Company Overview
10.2.3.2. Product Portfolio
10.2.3.3. Strengths & Challenges
10.2.4. F. Hoffmann-la Roche Ltd
10.2.4.1. Company Overview
10.2.4.2. Product Portfolio
10.2.4.3. Strengths & Challenges
10.2.5. Illumina Inc
10.2.5.1. Company Overview
10.2.5.2. Product Portfolio
10.2.5.3. Strengths & Challenges
10.2.6. Qiagen Nv
10.2.6.1. Company Overview
10.2.6.2. Product Portfolio
10.2.6.3. Strengths & Challenges
10.2.7. Siemens Healthineers Ag
10.2.7.1. Company Overview
10.2.7.2. Product Portfolio
10.2.7.3. Strengths & Challenges
10.2.8. Thermo Fisher Scientific Inc
10.2.8.1. Company Overview
10.2.8.2. Product Portfolio
10.2.8.3. Strengths & Challenges

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us